Renal cancer management is challenging from diagnosis to treatment and follow-up. In
cases of small renal masses and cystic lesions the differential diagnosis of benign or …

Simple Summary Positron emission tomography (PET), typically combined with computed
tomography (CT), has become a critical advanced imaging technique in oncology. With …

Purpose We aimed to investigate the role of [68 Ga] Ga-FAPI-04 PET/CT and uptake
patterns of primary and metastatic lesions in patients with renal cell carcinoma (RCC) …

Renal cell carcinoma (RCC) is the sixth most common cancer among men and the ninth
among women, and its prognosis is closely correlated with metastasis. Targeted therapy and …

Simple Summary Renal medullary carcinoma (RMC) is a rare and highly aggressive renal
cell carcinoma, with a median survival of 13 months. Platinum-based chemotherapy is the …

Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer. Prognosis for
ccRCC is generally poor since it is largely resistant to chemo-and radiotherapy. Many …

Results: Several studies have shown similar sensitivity and specificity of fluoro-2-deoxy-2-d-
glucose-PET (FDG-PET) scan as compared to conventional CT scan for the initial diagnosis …

Objectives This study aimed to compare the diagnostic performance of 18 F-DCFPyL and 2-
deoxy-2-[18 F] fluoro-D-glucose (18 F-FDG PET/computed tomography in the restaging of …

Renal cell carcinoma (RCC) and urothelial carcinoma (UC) represent the third and second
most common genitourinary malignancies, trailing prostate cancer. 1 Both types of tumors …

Purpose To further assess the diagnostic performance of positron emission
tomography/computed tomography (PET/CT) in recurrent renal cell carcinoma (RCC) …